These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Clozapine versus other atypical antipsychotics for schizophrenia. Asenjo Lobos C, Komossa K, Rummel-Kluge C, Hunger H, Schmid F, Schwarz S, Leucht S. Cochrane Database Syst Rev; 2010 Nov 10; (11):CD006633. PubMed ID: 21069690 [Abstract] [Full Text] [Related]
5. Ziprasidone versus other atypical antipsychotics for schizophrenia. Komossa K, Rummel-Kluge C, Hunger H, Schwarz S, Bhoopathi PS, Kissling W, Leucht S. Cochrane Database Syst Rev; 2009 Oct 07; (4):CD006627. PubMed ID: 19821380 [Abstract] [Full Text] [Related]
6. Healthcare costs associated with treatment of bipolar disorder using a mood stabilizer plus adjunctive aripiprazole, quetiapine, risperidone, olanzapine or ziprasidone. Jing Y, Kim E, You M, Pikalov A, Tran QV. J Med Econ; 2009 Jun 07; 12(2):104-13. PubMed ID: 19527195 [Abstract] [Full Text] [Related]
11. Maintenance of response with atypical antipsychotics in the treatment of schizophrenia: a post-hoc analysis of 5 double-blind, randomized clinical trials. Stauffer V, Ascher-Svanum H, Liu L, Ball T, Conley R. BMC Psychiatry; 2009 Mar 31; 9():13. PubMed ID: 19335905 [Abstract] [Full Text] [Related]